News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
149,778 Results
Type
Article (5226)
Company Profile (36)
Press Release (144516)
Section
Business (54479)
Career Advice (168)
Deals (10371)
Drug Delivery (7)
Drug Development (19388)
Employer Resources (59)
FDA (3591)
Job Trends (3951)
News (86261)
Policy (6570)
Tag
Academia (382)
Africa (121)
Alabama (9)
Allergies (9)
Alliances (7284)
Alzheimer's disease (409)
Approvals (3585)
Arizona (9)
Artificial intelligence (5)
Asia (8471)
Australia (1381)
Bankruptcy (73)
Best Places to Work (3497)
Biosimilars (15)
C2C Services and Suppliers (12589)
California (185)
Canada (138)
Cancer (35)
Career advice (147)
Cell therapy (14)
Clinical research (15360)
Collaboration (7)
Colorado (11)
Compensation (9)
Connecticut (9)
COVID-19 (435)
Cystic fibrosis (20)
Data (6)
Delaware (10)
Diabetes (5)
Diagnostics (1895)
Diversity, equity & inclusion (15)
Earnings (37164)
Employer branding (10)
Employer resources (45)
Europe (19496)
Events (23893)
Executive appointments (5)
FDA (3606)
Florida (32)
Gene therapy (11)
Georgia (9)
GLP-1 (132)
Government (809)
Healthcare (5045)
Hotbed/Location (110641)
Idaho (12)
Illinois (29)
Indiana (54)
Infectious disease (437)
Inflammatory bowel disease (17)
Interviews (17)
IPO (6595)
Job creations (461)
Job search strategy (140)
Kansas (40)
Labor market (5)
Layoffs (77)
Legal (1226)
Liver cancer (18)
Maine (40)
Management (13)
Manufacturing (5)
Maryland (100)
Massachusetts (119)
Medical device (3989)
Medtech (3990)
Mergers & acquisitions (3716)
Metabolic disorders (30)
Neuroscience (421)
New Jersey (15)
New York (16)
NextGen Class of 2024 (1088)
Non-profit (865)
North Carolina (40)
Obesity (20)
Opinion (47)
Parkinson's disease (6)
Peanut (9)
Pennsylvania (8)
People (7854)
Phase I (4348)
Phase II (6600)
Phase III (5745)
Postmarket research (589)
Preclinical (1593)
Rare diseases (23)
Real estate (717)
Recruiting (21)
Regulatory (4682)
Reports (25)
Research institute (394)
Resumes & cover letters (18)
South America (211)
Startups (378)
Texas (25)
United States (823)
Vaccines (75)
Washington State (48)
Weight loss (18)
Date
Today (24)
Last 7 days (110)
Last 30 days (499)
Last 365 days (13629)
2024 (6027)
2023 (29235)
2022 (11831)
2021 (12920)
2020 (12516)
2019 (9479)
2018 (7088)
2017 (7113)
2016 (5609)
2015 (7722)
2014 (4869)
2013 (3289)
2012 (4053)
2011 (4397)
2010 (3710)
149,778 Results for "27".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
Genetic Technologies Limited is pleased to invite investors to a webinar on June 27, 2024, at 4:15 p.m. ET.
June 21, 2024
·
3 min read
BioHarvest Sciences to Present at Noble Capital Markets Virtual Equity Conference on June 27, 2024
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) (“BioHarvest” or the “Company”), a company pioneering its patented Botanical Synthesis technology platform, today announced that management will present at the Noble Capital Markets Virtual Equity Conference, being held June 26-27, 2024.
June 24, 2024
·
2 min read
Biotech Beach
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024
Aethlon Medical, Inc. today announced that it will issue financial results for its fiscal year ended March 31, 2024 , at 4:15 p.m. ET on Thursday, June 27, 2024.
June 21, 2024
·
2 min read
Business
Biotricity to Host Fourth Quarter and Fiscal Year 2024 Financial Results and Business Update Call on June 27
Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, announced that it will host its fourth quarter and fiscal year 2024 financial results and business update call on Thursday, June 27, 2024.
June 26, 2024
·
4 min read
Female Infertility Market to Reach US$ 2.7 Billion by 2034, Impelled by Continual Technological Advancements
Analysts at IMARC expect the global female infertility market to reach US$ 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 2.76% during 2024-2034.
May 31, 2024
·
9 min read
Pharm Country
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical stage pharmaceutical company, today announced that management will participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on Thursday, June 27, 2024.
June 20, 2024
·
2 min read
Molecular Diagnostics Market Size & Companies Report | USD 25.27 Billion by 2032 | 5.3% - CAGR
The molecular diagnostics market size reached a value of $15.42 billion in 2023 and is expected to rise to $25.27 billion by 2032, growing at a CAGR of 5.3% for the forecast period from 2024 to 2032.
May 28, 2024
·
3 min read
Cybin to Participate at the 27th Annual Milken Institute Global Conference
Cybin Inc. today announced that Doug Drysdale, Cybin’s Chief Executive Officer, will be speaking at the 27th Annual Milken Institute Global Conference on a panel entitled “Collaborating for Improved Mental Health.”
April 25, 2024
·
6 min read
Genetown
Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference
Prime Medicine, Inc. today announced that Keith Gottesdiener, M.D., President and Chief Executive Officer of Prime Medicine, will participate in a panel discussion at the 27th Annual Milken Institute Global Conference entitled “Things That Will Blow Your Mind.”
May 1, 2024
·
2 min read
Drug Development
Roche Sees Early ROI on $2.7B Carmot Buy with Phase I Data for Obesity Candidate
Roche’s $2.7 billion acquisition of Carmot Therapeutics in December 2023 appears to be paying off as its investigational GLP-1/GIP receptor agonist induced strong weight loss in a Phase Ib study.
May 16, 2024
·
2 min read
·
Tristan Manalac
1 of 14,978
Next
